ArticleBreast cancer research and treatment2023

Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis.

Joyce M Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.